Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Compound methoxyphenamine sustained release preparation

A technology for methoxyphenamine and sustained-release preparations, which is applied to medical preparations containing no active ingredients, medical preparations containing active ingredients, and pill delivery, etc. Methoxyphenamine products do not have problems such as sustained release

Active Publication Date: 2011-10-12
SALUS PHARMA TECH SHANGHAI
View PDF3 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] Chinese patent 200410065967.4 discloses a preparation method for oral solid preparations containing methoxypheniramine, narcotine, aminophylline, and chlorpheniramine maleate. The compound methoxyphenamine product obtained by this method does not have sustained release release effect
According to the existing methods of taking medicines on the market, not only the dosage is relatively large, but also the number of takings is many, which is not conducive to ensuring that patients take medicine on time

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Compound methoxyphenamine sustained release preparation
  • Compound methoxyphenamine sustained release preparation
  • Compound methoxyphenamine sustained release preparation

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0093] Example 1: Compound tablet with sustained release up to 12 hours

[0094]

[0095] Preparation Process:

[0096] According to the proportion of the above formula, the active ingredients (methoxamine, noscapine, aminophylline, chlorpheniramine maleate) are mixed with hydroxypropyl methylcellulose and xanthan gum and stirred evenly; add an appropriate amount of The ethanol solution is stirred into fine particles and dried; pulverized to make them all pass through the No. 2 sieve of the Chinese Pharmacopoeia; the pulverized particles are added with filler microcrystalline cellulose and lubricant magnesium stearate, and compressed into tablets;

Embodiment 2

[0097] Example 2: Compound tablet with sustained release up to 24 hours

[0098]

[0099]

[0100] Preparation Process:

[0101] According to the ratio of the above-mentioned formula amount, the active ingredients (methoxyphenamine, noscapine, aminophylline, chlorpheniramine maleate) are mixed with hydroxypropyl methylcellulose and sodium alginate and stirred evenly; add an appropriate amount of The ethanol solution is stirred into fine particles and dried; pulverized to make them all pass through the No. 2 sieve of the Chinese Pharmacopoeia; the pulverized particles are added with filler microcrystalline cellulose and lubricant magnesium stearate, and compressed into tablets;

Embodiment 3

[0102] Example 3: Compound capsules with sustained release up to 12 hours

[0103]

[0104] Preparation Process:

[0105] The active ingredients (Methoxamine, Noscapine, Aminophylline, Chlorpheniramine Maleate), polyethylene glycol, sodium alginate and filler microcrystalline cellulose are mixed and stirred according to the above formula amounts Evenly; add an appropriate amount of aqueous solution, use an extrusion spheronizer to form pellets with a diameter of about 1.0mm, dry them, and put them into capsules;

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
diameteraaaaaaaaaa
Login to View More

Abstract

The invention discloses a sustained release preparation of which the active components comprise methoxyphenamine or hydrochloride thereof, narcotine, aminophylline and chlorphenamine maleate, wherein the ratio of the active components to sustained release auxiliary materials is 1:0.03 to 1:30, preferably 1:0.05 to 1:16, more preferably 1:0.08 to 1:10, and the drug is controlled to continuously release for 12-24 hours. The compound sustained release preparation comprises tablets, capsules and suspension.

Description

technical field [0001] The invention relates to a compound sustained-release preparation containing methoxnamin or its hydrochloride, noscapine, aminophylline, and chlorpheniramine maleate, which can be continuously released for 12 to 24 hours. Background technique [0002] Compound methoxyphenamine is an anti-asthma drug used for bronchial asthma and asthmatic bronchitis. Methoxynamine or its hydrochloride salt inhibits bronchospasm and relieves cough during asthma attacks. Nacodin is a peripheral cough suppressant that suppresses cough. Aminophylline can also inhibit bronchospasm, and can inhibit the swelling of bronchial mucosa, relieve cough during asthma attack, and make phlegm easy to cough up. Chlorpheniramine maleate has antihistamine properties. The compatibility of this product can not only relieve cough caused by throat and bronchial inflammation, but also relieve cough during asthma attack, which is beneficial to expectoration. At present, the taking method o...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/522A61K31/137A61K31/4741A61K31/4402A61K9/22A61K9/52A61K9/10A61P11/06A61P11/14
CPCA61K9/0095A61K9/1652A61K9/205A61K9/2054A61K9/5042A61K31/137A61K31/4402A61K31/4741A61K31/522A61K47/36A61K47/38A61P11/06A61P11/14
Inventor 田武王诺郑礼亮
Owner SALUS PHARMA TECH SHANGHAI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com